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Cellular signalingAngiotensin II (Ang II) stimulates the proximal tubule Na+-ATPase through the AT1 receptor/phosphoinositide
phospholipase Cβ (PI-PLCβ)/protein kinase C (PKC) pathway. However, this pathway alone does not explain
the sustained effect of Ang II on Na+-ATPase activity for 30 min. The aim of the present work was to elucidate
themolecularmechanisms involved in the sustained effect of Ang II on Na+-ATPase activity. Ang II induced fast
and correlated activation of Na+-ATPase and PKC activities with the maximal effect (115%) observed at 1 min
and sustained for 30 min, indicating a pivotal role of PKC in the modulation of Na+-ATPase by Ang II. We
observed that the sustained activation of PKC by Ang II depended on the sequential activation of phospholipase
D and Ca2+-insensitive phospholipase A2, forming phosphatidic acid and lysophosphatidic acid, respectively.
The results indicate that PKC could be the ﬁnal target and an integrator molecule of different signaling
pathways triggered by Ang II, which could explain the sustained activation of Na+-ATPase by Ang II.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Sodium reabsorption in proximal tubule cells is a crucial step in the
determination of renal sodium excretion [1,2]. The electrochemical
sodiumgradient in these cells depends on two sodiumpumps located in
the basolateralmembrane (BLM): classic ouabain-sensitive (Na++K+)
ATPase and ouabain-insensitive, furosemide-sensitive Na+-ATPase,
called the second sodium pump [3–5]. The observation that Na+-ATPase
is about 10 times less active than (Na++K+)ATPase [5,6] suggests that
this enzymemay be involved in ﬁne tuning, whereas (Na++K+)ATPase
is responsible for most of the Na+ reabsorption in the proximal tubule.
It has been shown that proximal tubule Na+-ATPase is a target for
several hormones and autacoids involved in the modulation of renal
sodium excretion, including angiotensin II (Ang II) [7]. Usually, the
effects of Ang II are mediated by two G protein coupled receptor
subtypes: AT1 and AT2 [8]. The AT1 receptors can be coupled to
multiple cellular signaling cascades with distinct temporal character-
istics [9]. It has been shown that activation of the AT1 receptor in a
variety of cell types induces several pathways, such as phospholipases
and kinases [9,10]. However, the role of these pathways in the
modulation of Na+-ATPase by Ang II is not completely understood.
In a previous work, we showed that Ang II stimulates Na+-ATPase
of proximal tubule BLM via AT1 receptors, in a process that involves: +55 21 2280 8193.
).
ll rights reserved.PKC and the transient activation of Gq-protein-mediated activation of
phosphoinositide phospholipase Cβ (PI-PLCβ) [7,11,12]. The effect of
Ang II on Na+-ATPase activity was observed even after 30 min of
incubation, although the activation of PI-PLCβwas maximal after 30 s
and returned to basal values after 1 min, suggesting a possible
involvement of other signaling pathways in Ang II-mediated stimu-
lation of Na+-ATPase.
The aim of this work was to elucidate the molecular mechanisms
involved in the sustained effect of Ang II on this enzyme activity. The
possible role of phospholipase D and phospholipase A2 was evaluated.
Isolated BLMs of proximal tubules were used because, in this
preparation, Ang II modulates Na+-ATPase activity without changes
in (Na++K+)ATPase activity [7]. We observed that Ang II promotes
sequential activation of the phospholipase D (PLD) and phospholipase
A2 (PLA2) pathways, after fast activation of PI-PLCβ, leading to
phosphatidic acid (PA)/lysophosphatidic acid (LPA) production,
maintaining activation of PKC. This has several physiologic implica-
tions within a complex interacting network that is crucial to the
regulation of body homeostasis control.
2. Materials and methods
2.1. Materials
ATP (sodium salt), N6,2′-O-dibutyryladenosine 3′,5′-cyclic mono-
phosphate (d-cAMP, sodium salt), phorbol myristate acetate (PMA),
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piperazine N′-2-ethanesulfonic acid (HEPES), tris(trishydroxy-
methyl)-aminomethane (Tris), Ang II and histone were purchased
from Sigma Chemical Co. (St. Louis, MO, USA). Percoll was obtained
from Amersham Pharmacia Biotech (Uppsala, Sweden). Palmitoyl
triﬂuoromethyl ketone (PACOCF3), quinacrine, bromoenol lactone
(BEL) and calphostin C were purchased from Calbiochem (California,
USA). All other reagents were of the highest purity available. [32P]Pi
was obtained from the Institute of Energetic and Nuclear Research,
São Paulo, SP, Brazil and [γ-32P]ATP was prepared as described by
Maia et al. [13]. All solutions were prepared with deionized glass-
distilled water.
2.2. Preparation of isolated basolateral membranes
BLMs were prepared from the outer cortex of adult pig kidneys.
The kidneys were obtained from a commercial slaughter house
immediately after the death of the animals and maintained in a cold
solution containing (mM): sucrose 250, Hepes–Tris (pH 7.6) 10, EDTA
2 and phenylmethylsulfonyl ﬂuoride (PMSF) 1. Thin slices of outer
cortex were removed using a scalpel. After dissection, the slices were
homogenized in the same cold solution with a Teﬂon and glass
homogenizer. The homogenate was centrifuged at 3000 rpm in a
SCR20B centrifuge using an RP12-2 rotor (Hitachi) for 10 min at 4 °C.
The supernatant was collected and stored at 4 °C. The fraction
enriched in BLMs was isolated by the Percoll gradient method [14].
The membrane preparation was resuspended in 250 mM sucrose at a
ﬁnal concentration of 5–10 mg protein ml−1 and stored at −20 °C.
The (Na++K+)ATPase activity, a marker for BLMs, was 7–8 times
higher than the activity found in the cortex. The same enrichment was
observed for Na+-ATPase speciﬁc activity. On the other hand, the
speciﬁc activities of alkaline phosphatase and 5′-nucleotidase,
markers of luminal membrane, were only enriched 1.2- and 0.25-
fold, respectively. Residual contamination with other subcellular
membrane fractions was minimal [15,16]. The protein concentration
was determined by the Folin phenol method [17] using bovine serum
albumin as a standard.
2.3. Measurement of ATPase activity
ATPase activity was measured according to the method described
by Grubmeyer and Penefsky [18]. The composition of the assay
medium for the measurement of Na+-ATPase activity (0.1 ml) was
4 mMMgCl2, 4 mM ATP (speciﬁc activity of approx. 104 Bq nmol−1 of
[γ-32P]ATP), 20 mM Hepes/Tris, pH 7.0, 90 mM NaCl, and 1 mM
ouabain. The speciﬁc inhibitors, antagonists and/or activator were
addedwhen indicated. The reactionwas started by adding protein to a
ﬁnal concentration of 0.3–0.5mg/ml, andwas stopped after 10min by
adding 0.1 M HCl-activated charcoal. The [32P]Pi released was
measured in an aliquot of 0.2 ml of the supernatant obtained after
centrifugation of the charcoal suspension for 5 min at 1500 g in a
clinical centrifuge. Spontaneous hydrolysis of [γ-32P]ATP was mea-
sured simultaneously in tubes to which protein was added after the
acid. The Na+-ATPase activity was calculated from the difference
between the [32P]Pi released in the absence and in the presence of
2 mM furosemide, both in the presence of 1 mM ouabain. The
possibility that there is vesicle formation in our preparation can be
ruled out because: (1) the isolated BLM (Na++K+)ATPase activity in
the presence of alamethicin (0.05 mg/mg protein), a permeabilizing
agent that provides free access for ions, ATP, and other reactants to the
interior of sealed vesicles, was not signiﬁcantly different from that
obtained in the absence of the drug (data not shown); (2) sodium- and
potassium-stimulated (Na++K+)ATPase activities were not signiﬁ-
cantly different (less than 10% of difference) (data not shown).
Probably the low percentage of inside-out vesicles is due to storage of
the preparation at−4 °C instead of−80 °C for at least 1 week.2.4. Protein kinase C activity assay
The PKC activity of isolated BLMs was measured by PKC-
calphostin-sensitive incorporation of [32P]Pi from [γ32-P]ATP
(7 μCi μmol−1), using histone as substrate. The composition of the
reaction medium was: 4 mM MgCl2, 20 mM HEPES–Tris (pH 7.0),
1.5 mg/ml histone and 0.7 mg/ml protein. After 10 min, the reaction
was stopped with 40% trichloroacetic acid (TCA) and the sample
immediately placed on ice. An aliquot (0.1 ml) was ﬁltered through a
Millipore ﬁlter (0.45 μm) and washed with ice-cold 20% TCA solution
and 0.1 M phosphate buffer (pH 7.0). The radioactivity was quantiﬁed
by liquid scintillation counting (Packard Tri-Carb 2100 TR). The
speciﬁc PKC was calculated from the difference between the activity
in the absence and in the presence of 10−8 M calphostin C. Phorbol
myristate acetate (PMA) was used as PKC activator.
2.5. Measurement of phospholipase activity
PLD activity was measured as described by Chalifa et al. [19],
quantifying the [14C]phosphatidic acid (PA) or [14C]phosphatidyl
ethanol (PEt) released using [14C]phosphatidylcholine (PC) as
substrate. The substrate was sonicated in medium containing 1-
hexadecyl-2[14C]arachdonyl-sn-glycerol-3-phosphocholine, sodium
oleate 25 mM and cold PC to a speciﬁc activity of 420 mCi/mol. The
reaction was started by the addition of the substrate to the medium
assay with: MgCl2 1 mM, Hepes-Na 50 mM (pH 7.2), EGTA 1 mM,
ethanol 2% (when indicated) and 0.3 mg/ml BLM protein. After
15 min at 37 °C the reaction was stopped by the addition of
chloroform/methanol/HCl (1:1:0.006, v/v/v). The lipid fraction was
extracted and separated using thin layer chromatography (TLC) on
silica gel plates. The eluent mixture usedwas ethyl acetate/isooctane/
acetic acid/water (13:2:3:10, v/v/v/v). Iodide vapor was then used to
reveal the bands. The bands corresponding to PA or PEt were scraped
and counted using liquid scintillation (Packard Tri-Carb 2100TR,
Illinois, USA).
The PLA activity was measured as described by Yang et al. [20]
using 100 μM dipalmitoylphosphatidylcholine (containing
5.0×105 cpm 1-palmitoyl-2-[1-14C]palmitoyl L-3-phosphatidylcho-
line) in 0.8 mM Triton X-100, micelles in 200 mM Hepes (pH 7.0),
5 mM EDTA, and 2 mM 1 mM dithiothreitol (DTT). The reaction was
started by the addition of BLM protein (0.1–0.3 mg/ml) at 37 °C. The
lipid extraction was performed as described by Horowitz and Perlman
[21], and modiﬁed by Malaquias and Oliveira [22]. The lipid samples
were applied to TLC silica gel plates using two solvent systems: CHCl3/
CH3OH/H2O (65:35:5, v/v/v) and C6H14/CH3CH2OCH2CH3/CHOOH
(90:60:4, v/v/v). The region corresponding to free fatty acids was
identiﬁed after exposure with iodide vapor, scraped and submitted to
liquid scintillation counting (Packard Tri-Carb 2100TR, Illinois, USA).
2.6. Data analysis
The means were compared by one-way analysis of variance
(ANOVA) taking into account the treatment of the experimental
groups. The magnitudes of the differences were evaluated using the
multiple comparative Bonferroni test. The data are presented as the
mean±standard error.
3. Results and discussion
3.1. Correlation between Na+-ATPase and PKC activities
To test for a possible temporal correlation between activation of
Na+-ATPase and PKC activities by Ang II, isolated BLM was incubated
with Ang II 10−8 M for different times (30 s up to 30 min). The Na+-
ATPase and PKC activities were thenmeasured in parallel (Fig. 1). Ang
II induced fast and correlated activation of both Na+-ATPase and PKC
Fig. 1. The effect of time of Ang II incubation on Na+-ATPase (closed circles) and PKC
(open triangles) activity. BLM was incubated with 10−8 M Ang II and the enzyme
activities were measured at different times as described in Section 2 (n=6). The results
are expressed as the mean±SE. The Na+-ATPase and PKC activities in the absence
ofAng IIwere 24.3±3.1nmolPimg−1min−1 and41.2±5.5nmol P-histonemg−1min−1,
respectively. ⁎Statistically signiﬁcant when compared to controls (pb0.05).
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conditions, the enzyme activities were increased by around 115% and
this was sustained for 30min. These data agreewith those observed in
a previous work where Ang II increased Na+-ATPase activity through
activation of a Ca2+-insensitive, PMA-sensitive PKC, probably belong-
ing to a novel family subtype [11]. Usually members of this family are
activated by an increase in the level of diacylglycerol (DAG), which
can be generated by activation of PI-PLCβ. We showed that 10−8 M
Ang II activated PI-PLCβ activity in a fast and transient way; theFig. 2. Involvement of PLD on themodulation of Na+-ATPase activity by Ang II. (A) Time
course of PA. BLM was incubated with 10−8 M Ang II for different times and the
formation of PA was measured by TLC as described in Section 2 (n=4). Inset: the effect
of Ang II on PEt formation. BLMwas incubated with 10−8 M Ang II for 5 min (n=3). (B)
Effect of Ang II on Na+-ATPase activity (black bars) and PA formation (gray bars). Open
bar represents the control conditions taken as 100% for each reaction. BLM was
incubated with 10−8 M Ang II for 30 or 5 min to measure the Na+-ATPase activity or PA
formation, respectively (n=8). The results are expressed as mean±SE. ⁎Statistically
signiﬁcant when compared to controls. #Statistically signiﬁcant when compared to the
enzyme activity obtained in the presence of 10−8 M Ang II. pb0.05 under all conditions.maximal effect occurred after 1 min of incubation and then returned
to the control level [12]. Together these results lead us to postulate
that PKC could be the ﬁnal target and an integrator molecule of
different signaling pathways triggered by Ang II, which could explain
the sustained activation of Na+-ATPase by Ang II.
3.2. PLD/PA and iPLA2/LPA pathways are involved in the sustained
effect of Ang II on Na+-ATPase activity
Based on phospholipid metabolism, it is known that PLD may be
involved in the sustained effect of a previous and transiently activated
PI-PLCβ pathway [23]. However, the activation of PLD in BLM of
proximal tubular cells has not yet been demonstrated. The physiologic
product of PLD action is phosphatidic acid (PA) [23]. We therefore
investigated whether Ang II stimulates PA synthesis in the BLMs of
proximal tubule from pig kidney. As depicted in Fig. 2A, Ang II 10−8 M
stimulates PA production with maximal effect at 6 min (200%), then
returning to the control value. One unique characteristic of PLD is its
ability to catalyze a particular reaction, called transphosphatidylation,
in which the polar head of PC is changed by a primary alcohol, such as
ethanol (EtOH), giving PEt and choline [24]. Incubation of isolated
BLMs for 5minwith 10−8 MAng II increased the formation of PEt (Fig.
2A, inset) conﬁrming the activation of PLD by Ang II. Because
transphosphatidylation occurs rather than hydrolysis reaction, the
addition of primary alcohols to the assay medium blocks PA synthesis
by PLD [24]. In thisway, the stimulatory effect of 10−8MAng II on Na+-
ATPase activity and PA formation was inhibited by 2% EtOH (Fig. 2B).
Ethanol (2%) alone did not change the pump activity. These results
indicate that PLD could mediate the effect of Ang II in proximal
tubule cells. Rothman et al. [25] showed that 2% EtOH inhibits Na+-
ATPase activity after the treatment of BLM with 1.5 μg SDS/μg of
protein. Because we did not use SDS in our reaction medium, the
difference between our results and Rothman's results could be due to
the inﬂuence of the Na+-ATPase phospholipid environment. To test
this hypothesis we carried out simultaneous experiments in the
presence or in the absence of SDS (0.4 μg SDS/μg protein). It was
observed that 2% EtOH inhibited the enzyme activity in 52% in the
presence of SDS and did not change the enzyme activity in the
absence of it (data not shown). Furthermore, Table 3 of Rothman et
al. showed that the Na+-ATPase activity of homogenates from rat
kidney cortex slices pre-incubated in an isotonic medium did not
change with the addition of 2% ethanol. On the other hand, when the
rat kidney cortex slices were incubated with hypotonic medium,
inhibition of the Na+-ATPase activity was observed. These results
show that the effect of ethanol depends on previous swelling of the
cells and is probably not a direct effect on the enzyme activity.
Because we use isolated basolateral membranes, it is not possible that
the swelling of the cells occurred.
Fig. 3A shows the effect of PA on Na+-ATPase activity. The dose–
response curve of PA (10−13 to 10−8 g/ml) on Na+-ATPase shows a
progressive enhancement of the enzyme activity, with the maximum
effect (100%) achieved at 10−11 g/ml. The stimulatory effect of PAwas
already observed at concentrations as low as 10−13 g/l. Furthermore,
the simultaneous addition of 10−9 g/l PA and 10−8 M Ang II to the
reactionmedium stimulates Na+-ATPase activity in a similar and non-
additive manner (Fig. 3B). Based on our hypothesis that PKC could be
the ﬁnal target and the integrator of different signaling pathways
triggered by Ang II, we investigated whether PKC is involved in the
effect of PA on Na+-ATPase activity. Fig. 3B shows that PA-stimulated
or Ang II-stimulated Na+-ATPase activity were completely abolished
in the presence of 10−8 M PKC inhibitor, calphostin C, indicating that
PKC is involved in this process. Furthermore, 10−8 M calphostin C
alone did not change the Na+-ATPase activity.
So far our results show the involvement of the PI-PLC/PLD
pathway, mediating the effect of Ang II on Na+-ATPase activity.
However, the sequential activation of PI-PLCβ and PLD does not
Fig. 3. PA modulation of Na+-ATPase activity involves PKC. (A) Dose–response of
incubation with PA on Na+-ATPase activity (10−13–10−8 g/ml). BLM was incubated
with (closed circle) or without (open triangle) PA for 5 min and ATPase activity was
measured (n=5). (B) Modulation of the effect of PA on Na+-ATPase activity by 10−8 M
calphostin C (Cph). BLMwas incubatedwith 10−8M Ang II, 10−9 g/ml PA and/or 10−8M
Cph for 5 min when indicated and enzyme activity was measured (n=6). The results are
expressed as the mean±SE. ⁎Statistically signiﬁcant when compared to controls.
#Statistically signiﬁcant when compared to the enzyme activity obtained in the presence
of 10−9 g/ml PA. pb0.05 under all conditions.
Fig. 4. Involvement of PLA2 on the modulation of Na+-ATPase activity by Ang II. (A)
Time course of the effect of Ang II on PLA2 activity. BLMwas incubated with 10−8 M Ang
II for different times and the PLA2 activity was measured as described in Section 2
(n=5). (B) Modulation of the effect of Ang II on Na+-ATPase activity by PLA2 inhibitors.
When indicated, BLMwas incubatedwith10−8MAng II, 10−8Mquinacrine (Qui), 10−6M
PACOF3 and/or 10−8 M BEL for 5 min and the enzyme activity wasmeasured (n=4). The
results are expressed as the mean±SE. ⁎Statistically signiﬁcant when compared to
controls. #Statistically signiﬁcant when compared to the enzyme activity obtained in the
presence of 10−8 M Ang II. pb0.05 under all conditions.
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after 10 min, PI-PLCβ and PLD activities are not stimulated by Ang II,
while the activation of PKC activity is still observed. It is widely known
that Ang II stimulates PLA2 in some cellular types such as endothelium
and vasculature cells [26,27]. In our study, we investigated PLA2
activation by Ang II. Isolated BLMswere incubated with 10−8 M Ang II
for different times. After the reaction, the phospholipids were
separated using a TLC technique and PLA2 activity was quantiﬁed.
The temporal course shows an 8-fold increase in PLA2 activity in the
presence of 10−8 M Ang II, with the maximum effect reached at
10 min (Fig. 4A). This stimulus was sustained for 20 min and
decreased after 30 min. Even after 30 min, an increase in PLA2 activity
of 138% could still be observed. When PA synthesis is decreasing, the
release of palmitic acid, a product of PLA2 activity, is increasing,
showing a correlation between the decrease in substrate level (PA)
and the increase in product formation (palmitic acid and LPA). The
level of LPC did not change after the treatments (data not shown).
In a recent paper, we observed that isolated BLM presents
constitutive Ca2+-insensitive PLA2 (iPLA2) inhibited by quinacrine,
PACOCF3 and a speciﬁc inhibitor, BEL [28]. Fig. 4B shows that with the
addition of 10−8 M quinacrine, 10−6 M PACOCF3 or 10−6 M BEL, the
stimulatory effect of 10−8 M Ang II on Na+-ATPase activity did not
occur. It is well known that iPLA2 can metabolize PA generating LPA
[29], which exerts several biologic effects [30]. We investigated
whether LPA could modulate Na+-ATPase activity. The addition of
increasing doses of LPA (10−8 to 10−5 M) promoted a stimulatory
effect on the enzyme activity in a dose-dependent manner, with the
maximum value (120%) reached at 10−11 M (Fig. 5A). The correlationbetween the effect of LPA and PKC activity was shown by the
observation that the stimulatory effect of 10−8 M LPA on the enzyme
activity was reversed by 10−8 M PKC inhibitor, calphostin C (Fig. 5B).
In the next step we tested whether the effect of PA on Na+-ATPase
activity depends on iPLA2 activity. Fig. 6A shows that the stimulatory
effect of PA on the enzyme activity is completely abolished by the
addition of 10−6 M PACOF3 or 10−6 M BEL. Furthermore, this effect
was overcome by simultaneous addition of LPA, a product of the
breakdown of PA by iPLA2. Similar effects were observedwhen 10−8 M
Ang II was added instead of PA (Fig. 6B).
The results shown in the present work and previous observations
[7,11,12] suggest that Ang II modulation of proximal tubule Na+-
ATPase activity involves the activation of PI-PLCβ/PLD/iPLA2 and the
PKC of plasma membrane is the ﬁnal target and the integrating
component of these pathways. Studies on the role of PKC in the
modulation of renal sodium transporters have indicated that the
tissue speciﬁc distribution of different PKC isoforms is the determi-
nant of the ﬁnal effect of this kinase on renal sodium transporters [31].
We have already reported the presence of several components of
different signaling cascades such as PI-PLC/DAG/PKC and adenylyl
cyclase/cAMP/PKA and their functionality in isolated BLM. In
addition, we have shown that these pathways are coupled to several
receptors including angiotensin receptors, AT1 and AT2 [7,11,12,15,28].
The presence of complete signaling complexes in plasma membrane,
fromreceptors andall intermediary elements toﬁnalmembrane targets,
illustrates that isolated BLM is a suitable model for investigation of the
Fig. 5. PKC mediated the modulation of Na+-ATPase activity by LPA. (A) Dose–response
of incubation with LPA on Na+-ATPase activity (10−15–10−6 M). BLM was incubated
with (closed circle) or without (open triangle) LPA for 10 min and the Na+-ATPase
activity was measured (n=5). (B) Modulation of the effect of 10−8 M LPA or 10−12 M
phorbol ester (PMA) on Na+-ATPase activity by 10−8 M calphostin C (Cph). BLM was
incubatedwith 10−8M LPA or 10−12MPMA in the presence or in the absence of 10−8M
Cph for 10 min when indicated and the enzyme activity was measured (n=6). The
results are expressed as the mean±SE. ⁎Statistically signiﬁcant when compared to
controls. #Statistically signiﬁcantwhen compared to the enzyme activity obtained in the
presence of 10−8M LPA. πStatistically signiﬁcantwhen compared to the enzyme activity
obtained in the presence of 10−12 M PMA. pb0.05 under all conditions.
Fig. 6. The effect of PA on Na+-ATPase is mediated for LPA. (A) The effect of PA is
mediated by iPLA2; BLMwas incubated with 10−9 g/ml PA, 10−6 M BEL and/or 10−8 M
LPA for 10minwhen indicated and the Na+-ATPase activity was assayed as described in
Section 2 (n=5). (B) The effect of Ang II is mediated by iPLA2. BLM was incubated with
10−8M Ang II, 10−6M BEL and/or 10−8M LPA for 10minwhen indicated and the Na+-
ATPase activity was assayed as described in Section 2 (n=6). The results are expressed
as the mean±SE. ⁎Statistically signiﬁcant when compared to controls. #Statistically
signiﬁcant when compared to the enzyme activity obtained in the presence of 10−8 M
Ang II.
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modulation of Na+-ATPase. In the present study, we could correlate the
sustained activation of Na+-ATPase by Ang II with the activation of a
novel PKC isoform based on the following evidence: (1) the assay
mediumwas calcium-freewith EGTA added, ruling out the involvement
of a conventional PKC; (2) as shown previously, DAG and phorbol ester
stimulates the PKC present in our preparation, ruling out the
involvement of an atypical PKC.
In a previous paper, we showed that the effect of Ang II on Na+-
ATPase and PKC activity is mediated by AT1 receptor [11]. Thus, it is
plausible to postulate that Ang II increases PLD activity of BLM
through AT1 receptor. This hypothesis agrees with the observations
in several works, in which AT1 receptor mediates the activation of
PLD by Ang II in smooth muscle and endothelial cells [32]. It is well
established that there are close interactions between PKC and PLD in
the regulation of PLD by PKC, an issue that is still incompletely
understood [33]. Evidence suggests that PLD activation by PKC
requires an initial hydrolysis of PI lipids and DAG generation. In this
way, it is possible that previously PI-PLCβ-activated PKC could act as
the PLD activator. Our results show that the time course of PKC and
PLD activation supports PI-PLCβ/PKC-mediated PLD activation by
Ang II.
It has been reported that PA itself could act as an intracellular
second messenger [23]. In vitro studies showed that PA is able to
substitute PS in the activation of PKC [34]. On the other hand, PA could
be converted to DAG by PA phosphohydrolase leading to the
activation of PKC [23]. However, this possibility can be ruled outbecause: (1) the stimulatory effect of PA is completely reverted by
iPLA2 inhibitors, indicating that the effect PA depends on the further
activation of iPLA2; (2) LPA, the product of PA hydrolysis by iPLA2,
stimulates Na+-ATPase in a similar way to PA and Ang II. It has been
reported that PA could also be synthesized from DAG phosphorylation
by a DAG kinase (DGK); however, this does not seems to be the case
since PA synthesis is completely blocked by the addition of ethanol, a
PLD inhibitor.
The molecular mechanisms involved in the activation of iPLA2 are
poorly understood. In a previous study, we observed that PKC
activation led to an increase in iPLA2 activity [28]. In a similar way,
using membrane fractions of ventricular myocytes, Steer et al. [35]
showed that PMA increases iPLA2 through activation of a resident pool
of PKC. Although no phosphorylation consensus sequences have been
described in iPLA2, different studies suggest the involvement of
phosphorylation in the regulation of this enzyme [36–38]. These
results indicate that activation of PKC by previous activation of PI-
PLCβ and PLD by Ang II could mediate the activation of iPLA2 by this
peptide. The activation of these loops by PKC could represent an
important positive feedback within the Ang II-induced signaling
pathways involved in maintenance of the stimulatory effect on Na+-
ATPase activity.
The Na+-ATPase activity was always measured in the presence of
1 mM ouabain and in the absence of KCl. Under these conditions, the
(Na++K+)ATPase activity is completely inhibited, even the partial
reactions when K is absent. These results rule out the possibility that
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correlated with (Na++K+)ATPase or even with a partial reaction of
the catalytic cycle of this enzyme. Furthermore, it has been
demonstrated previously that 2 mM furosemide does not affect the
activities of other ATPases, such as (Na++K+)ATPase, Mg2+-ATPase,
Ca2+-ATPase and Ecto-ATPase [3–6].
The link between Na+-stimulated ATPase activity and Na+
transport was also shown by Malnic et al. [39]. They observed that
furosemide inhibits Na+ reabsorption in the proximal tubule. It is well
known that Ang II increases proximal tubule sodium reabsorption, but
themolecular mechanism is not completely understood. Furthermore,
it was shown that PKC activation leads to an increase in proximal
tubule sodium reabsorption [31]. Thus, it is possible to postulate that
the effect of Ang II on Na+-ATPase activity is mediated, at least in part,
by the effect of Ang II on sodium reabsorption in proximal tubule cells
through an AT1R/PI-PLCβ/PLD/iPLA2 pathway, which is integrated by
activation of PKC.
The results obtained in this work, together with previous data
from the literature, suggest extensive cross-talk between cellular
signaling pathways triggered by a single initial effector, Ang II. Ang II is
a crucial peptide to body homeostasis, and exerts multiple functions
as hormone, cytosine and autacoid. Determination of the molecular
mechanisms involved in Ang II modulation of sodium transporters is
fundamental to our comprehension of physiologic extracellular
volume regulation and opens new possibilities for possible pharma-
cologic interventions in pathologic conditions such as hypertension.
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